Evidence map›Paper›PMID 11023819›Full record

ArticleThe Biochemical journal2000

Evaluation of the role of two conserved active-site residues in beta class glutathione S-transferases.

N Allocati, E Casalone, M Masulli, G Polekhina, J Rossjohn, M W Parker, C Di Ilio

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. A Novel GlutathioneToxins · 2021
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

N AllocatiDipartimento di Scienze Biomediche, Università 'G. D'Annunzio', Via dei Vestini 31, I-66013 Chieti, Italy.
E Casalone
M Masulli
G Polekhina
J Rossjohn
M W Parker
C Di Ilio
University of Chieti-Pescara · ITSt Vincents Institute of Medical Research · AUIan Potter Foundation · AUUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutathione S-transferases (GSTs) normally use hydroxy-group-containing residues in the N-terminal domain of the enzyme for stabilizing the activated form of the co-substrate, glutathione. However, previous mutagenesis studies have shown that this is not true for Beta class GSTs and thus the origin of the stabilization remains a mystery. The recently determined crystal structure of Proteus mirabilis GST B1-1 (PmGST B1-1) suggested that the stabilizing role might be fulfilled in Beta class GSTs by one or more residues in the C-terminal domain of the enzyme. To test this hypothesis we mutated His(106) and Lys(107) of PmGST B1-1 to investigate their possible role in the enzyme's catalytic activity. His(106) was mutated to Ala, Asn and Phe, and Lys(107) to Ala and Arg. The effects of the replacement on the activity, thermal stability and antibiotic-binding capacity of the enzyme were examined. The results are consistent with the involvement of His(106) and Lys(107) in interacting with glutathione at the active site but these residues do not contribute significantly to catalysis, folding or antibiotic binding.

Indexed as

AlanineAmino Acid SequenceAnti-Bacterial AgentsArginineAsparagineBinding SitesCatalysisConserved SequenceDose-Response Relationship, DrugEscherichia coliGlutathione TransferaseGuanidineHistidineLysineMolecular Sequence DataMutagenesis, Site-DirectedAlanineAnti-Bacterial AgentsArginineAsparagineGlutathione TransferaseGuanidineHistidineLysinePhenylalanineRifamycins

Identifiers

PMID11023819
PMCPMC1221369
OpenAlexW2094939640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.